Submucosal Injectable Composition Market, Global Outlook and Forecast 2022-2028
Submucosal Injectable Composition is designed to be used for submucosal lift of polyps, adenomas, early-stage cancers or other gastrointestinal mucosal lesions prior to excision with a snare or other endoscopic device.
This report contains market size and forecasts of Submucosal Injectable Composition in global, including the following market information:
Global Submucosal Injectable Composition Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Submucosal Injectable Composition Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Submucosal Injectable Composition companies in 2021 (%)
The global Submucosal Injectable Composition market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Prefilled Syringes Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Submucosal Injectable Composition include Boston Scientific, The Standard, EndoClot Plus, GI Supply, Cosmo Pharmaceuticals, Ovesco and Seikagaku, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Submucosal Injectable Composition manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Submucosal Injectable Composition Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Submucosal Injectable Composition Market Segment Percentages, by Type, 2021 (%)
Global Submucosal Injectable Composition Market Segment Percentages, by Application, 2021 (%)
Global Submucosal Injectable Composition Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Submucosal Injectable Composition revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Submucosal Injectable Composition revenues share in global market, 2021 (%)
Key companies Submucosal Injectable Composition sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Submucosal Injectable Composition sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Submucosal Injectable Composition in global, including the following market information:
Global Submucosal Injectable Composition Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Submucosal Injectable Composition Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Submucosal Injectable Composition companies in 2021 (%)
The global Submucosal Injectable Composition market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Prefilled Syringes Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Submucosal Injectable Composition include Boston Scientific, The Standard, EndoClot Plus, GI Supply, Cosmo Pharmaceuticals, Ovesco and Seikagaku, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Submucosal Injectable Composition manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Submucosal Injectable Composition Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Submucosal Injectable Composition Market Segment Percentages, by Type, 2021 (%)
- Prefilled Syringes
- Vial
Global Submucosal Injectable Composition Market Segment Percentages, by Application, 2021 (%)
- Hospitals
- Clinics
- Others
Global Submucosal Injectable Composition Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Submucosal Injectable Composition revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Submucosal Injectable Composition revenues share in global market, 2021 (%)
Key companies Submucosal Injectable Composition sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Submucosal Injectable Composition sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Boston Scientific
- The Standard
- EndoClot Plus
- GI Supply
- Cosmo Pharmaceuticals
- Ovesco
- Seikagaku
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Submucosal Injectable Composition Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Submucosal Injectable Composition Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL SUBMUCOSAL INJECTABLE COMPOSITION OVERALL MARKET SIZE
2.1 Global Submucosal Injectable Composition Market Size: 2021 VS 2028
2.2 Global Submucosal Injectable Composition Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Submucosal Injectable Composition Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Submucosal Injectable Composition Players in Global Market
3.2 Top Global Submucosal Injectable Composition Companies Ranked by Revenue
3.3 Global Submucosal Injectable Composition Revenue by Companies
3.4 Global Submucosal Injectable Composition Sales by Companies
3.5 Global Submucosal Injectable Composition Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Submucosal Injectable Composition Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Submucosal Injectable Composition Product Type
3.8 Tier 1, Tier 2 and Tier 3 Submucosal Injectable Composition Players in Global Market
3.8.1 List of Global Tier 1 Submucosal Injectable Composition Companies
3.8.2 List of Global Tier 2 and Tier 3 Submucosal Injectable Composition Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Submucosal Injectable Composition Market Size Markets, 2021 & 2028
4.1.2 Prefilled Syringes
4.1.3 Vial
4.2 By Type - Global Submucosal Injectable Composition Revenue & Forecasts
4.2.1 By Type - Global Submucosal Injectable Composition Revenue, 2017-2022
4.2.2 By Type - Global Submucosal Injectable Composition Revenue, 2023-2028
4.2.3 By Type - Global Submucosal Injectable Composition Revenue Market Share, 2017-2028
4.3 By Type - Global Submucosal Injectable Composition Sales & Forecasts
4.3.1 By Type - Global Submucosal Injectable Composition Sales, 2017-2022
4.3.2 By Type - Global Submucosal Injectable Composition Sales, 2023-2028
4.3.3 By Type - Global Submucosal Injectable Composition Sales Market Share, 2017-2028
4.4 By Type - Global Submucosal Injectable Composition Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Submucosal Injectable Composition Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Submucosal Injectable Composition Revenue & Forecasts
5.2.1 By Application - Global Submucosal Injectable Composition Revenue, 2017-2022
5.2.2 By Application - Global Submucosal Injectable Composition Revenue, 2023-2028
5.2.3 By Application - Global Submucosal Injectable Composition Revenue Market Share, 2017-2028
5.3 By Application - Global Submucosal Injectable Composition Sales & Forecasts
5.3.1 By Application - Global Submucosal Injectable Composition Sales, 2017-2022
5.3.2 By Application - Global Submucosal Injectable Composition Sales, 2023-2028
5.3.3 By Application - Global Submucosal Injectable Composition Sales Market Share, 2017-2028
5.4 By Application - Global Submucosal Injectable Composition Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Submucosal Injectable Composition Market Size, 2021 & 2028
6.2 By Region - Global Submucosal Injectable Composition Revenue & Forecasts
6.2.1 By Region - Global Submucosal Injectable Composition Revenue, 2017-2022
6.2.2 By Region - Global Submucosal Injectable Composition Revenue, 2023-2028
6.2.3 By Region - Global Submucosal Injectable Composition Revenue Market Share, 2017-2028
6.3 By Region - Global Submucosal Injectable Composition Sales & Forecasts
6.3.1 By Region - Global Submucosal Injectable Composition Sales, 2017-2022
6.3.2 By Region - Global Submucosal Injectable Composition Sales, 2023-2028
6.3.3 By Region - Global Submucosal Injectable Composition Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Submucosal Injectable Composition Revenue, 2017-2028
6.4.2 By Country - North America Submucosal Injectable Composition Sales, 2017-2028
6.4.3 US Submucosal Injectable Composition Market Size, 2017-2028
6.4.4 Canada Submucosal Injectable Composition Market Size, 2017-2028
6.4.5 Mexico Submucosal Injectable Composition Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Submucosal Injectable Composition Revenue, 2017-2028
6.5.2 By Country - Europe Submucosal Injectable Composition Sales, 2017-2028
6.5.3 Germany Submucosal Injectable Composition Market Size, 2017-2028
6.5.4 France Submucosal Injectable Composition Market Size, 2017-2028
6.5.5 U.K. Submucosal Injectable Composition Market Size, 2017-2028
6.5.6 Italy Submucosal Injectable Composition Market Size, 2017-2028
6.5.7 Russia Submucosal Injectable Composition Market Size, 2017-2028
6.5.8 Nordic Countries Submucosal Injectable Composition Market Size, 2017-2028
6.5.9 Benelux Submucosal Injectable Composition Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Submucosal Injectable Composition Revenue, 2017-2028
6.6.2 By Region - Asia Submucosal Injectable Composition Sales, 2017-2028
6.6.3 China Submucosal Injectable Composition Market Size, 2017-2028
6.6.4 Japan Submucosal Injectable Composition Market Size, 2017-2028
6.6.5 South Korea Submucosal Injectable Composition Market Size, 2017-2028
6.6.6 Southeast Asia Submucosal Injectable Composition Market Size, 2017-2028
6.6.7 India Submucosal Injectable Composition Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Submucosal Injectable Composition Revenue, 2017-2028
6.7.2 By Country - South America Submucosal Injectable Composition Sales, 2017-2028
6.7.3 Brazil Submucosal Injectable Composition Market Size, 2017-2028
6.7.4 Argentina Submucosal Injectable Composition Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Submucosal Injectable Composition Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Submucosal Injectable Composition Sales, 2017-2028
6.8.3 Turkey Submucosal Injectable Composition Market Size, 2017-2028
6.8.4 Israel Submucosal Injectable Composition Market Size, 2017-2028
6.8.5 Saudi Arabia Submucosal Injectable Composition Market Size, 2017-2028
6.8.6 UAE Submucosal Injectable Composition Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Boston Scientific
7.1.1 Boston Scientific Corporate Summary
7.1.2 Boston Scientific Business Overview
7.1.3 Boston Scientific Submucosal Injectable Composition Major Product Offerings
7.1.4 Boston Scientific Submucosal Injectable Composition Sales and Revenue in Global (2017-2022)
7.1.5 Boston Scientific Key News
7.2 The Standard
7.2.1 The Standard Corporate Summary
7.2.2 The Standard Business Overview
7.2.3 The Standard Submucosal Injectable Composition Major Product Offerings
7.2.4 The Standard Submucosal Injectable Composition Sales and Revenue in Global (2017-2022)
7.2.5 The Standard Key News
7.3 EndoClot Plus
7.3.1 EndoClot Plus Corporate Summary
7.3.2 EndoClot Plus Business Overview
7.3.3 EndoClot Plus Submucosal Injectable Composition Major Product Offerings
7.3.4 EndoClot Plus Submucosal Injectable Composition Sales and Revenue in Global (2017-2022)
7.3.5 EndoClot Plus Key News
7.4 GI Supply
7.4.1 GI Supply Corporate Summary
7.4.2 GI Supply Business Overview
7.4.3 GI Supply Submucosal Injectable Composition Major Product Offerings
7.4.4 GI Supply Submucosal Injectable Composition Sales and Revenue in Global (2017-2022)
7.4.5 GI Supply Key News
7.5 Cosmo Pharmaceuticals
7.5.1 Cosmo Pharmaceuticals Corporate Summary
7.5.2 Cosmo Pharmaceuticals Business Overview
7.5.3 Cosmo Pharmaceuticals Submucosal Injectable Composition Major Product Offerings
7.5.4 Cosmo Pharmaceuticals Submucosal Injectable Composition Sales and Revenue in Global (2017-2022)
7.5.5 Cosmo Pharmaceuticals Key News
7.6 Ovesco
7.6.1 Ovesco Corporate Summary
7.6.2 Ovesco Business Overview
7.6.3 Ovesco Submucosal Injectable Composition Major Product Offerings
7.6.4 Ovesco Submucosal Injectable Composition Sales and Revenue in Global (2017-2022)
7.6.5 Ovesco Key News
7.7 Seikagaku
7.7.1 Seikagaku Corporate Summary
7.7.2 Seikagaku Business Overview
7.7.3 Seikagaku Submucosal Injectable Composition Major Product Offerings
7.7.4 Seikagaku Submucosal Injectable Composition Sales and Revenue in Global (2017-2022)
7.7.5 Seikagaku Key News
8 GLOBAL SUBMUCOSAL INJECTABLE COMPOSITION PRODUCTION CAPACITY, ANALYSIS
8.1 Global Submucosal Injectable Composition Production Capacity, 2017-2028
8.2 Submucosal Injectable Composition Production Capacity of Key Manufacturers in Global Market
8.3 Global Submucosal Injectable Composition Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 SUBMUCOSAL INJECTABLE COMPOSITION SUPPLY CHAIN ANALYSIS
10.1 Submucosal Injectable Composition Industry Value Chain
10.2 Submucosal Injectable Composition Upstream Market
10.3 Submucosal Injectable Composition Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Submucosal Injectable Composition Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Submucosal Injectable Composition Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Submucosal Injectable Composition Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL SUBMUCOSAL INJECTABLE COMPOSITION OVERALL MARKET SIZE
2.1 Global Submucosal Injectable Composition Market Size: 2021 VS 2028
2.2 Global Submucosal Injectable Composition Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Submucosal Injectable Composition Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Submucosal Injectable Composition Players in Global Market
3.2 Top Global Submucosal Injectable Composition Companies Ranked by Revenue
3.3 Global Submucosal Injectable Composition Revenue by Companies
3.4 Global Submucosal Injectable Composition Sales by Companies
3.5 Global Submucosal Injectable Composition Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Submucosal Injectable Composition Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Submucosal Injectable Composition Product Type
3.8 Tier 1, Tier 2 and Tier 3 Submucosal Injectable Composition Players in Global Market
3.8.1 List of Global Tier 1 Submucosal Injectable Composition Companies
3.8.2 List of Global Tier 2 and Tier 3 Submucosal Injectable Composition Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Submucosal Injectable Composition Market Size Markets, 2021 & 2028
4.1.2 Prefilled Syringes
4.1.3 Vial
4.2 By Type - Global Submucosal Injectable Composition Revenue & Forecasts
4.2.1 By Type - Global Submucosal Injectable Composition Revenue, 2017-2022
4.2.2 By Type - Global Submucosal Injectable Composition Revenue, 2023-2028
4.2.3 By Type - Global Submucosal Injectable Composition Revenue Market Share, 2017-2028
4.3 By Type - Global Submucosal Injectable Composition Sales & Forecasts
4.3.1 By Type - Global Submucosal Injectable Composition Sales, 2017-2022
4.3.2 By Type - Global Submucosal Injectable Composition Sales, 2023-2028
4.3.3 By Type - Global Submucosal Injectable Composition Sales Market Share, 2017-2028
4.4 By Type - Global Submucosal Injectable Composition Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Submucosal Injectable Composition Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Submucosal Injectable Composition Revenue & Forecasts
5.2.1 By Application - Global Submucosal Injectable Composition Revenue, 2017-2022
5.2.2 By Application - Global Submucosal Injectable Composition Revenue, 2023-2028
5.2.3 By Application - Global Submucosal Injectable Composition Revenue Market Share, 2017-2028
5.3 By Application - Global Submucosal Injectable Composition Sales & Forecasts
5.3.1 By Application - Global Submucosal Injectable Composition Sales, 2017-2022
5.3.2 By Application - Global Submucosal Injectable Composition Sales, 2023-2028
5.3.3 By Application - Global Submucosal Injectable Composition Sales Market Share, 2017-2028
5.4 By Application - Global Submucosal Injectable Composition Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Submucosal Injectable Composition Market Size, 2021 & 2028
6.2 By Region - Global Submucosal Injectable Composition Revenue & Forecasts
6.2.1 By Region - Global Submucosal Injectable Composition Revenue, 2017-2022
6.2.2 By Region - Global Submucosal Injectable Composition Revenue, 2023-2028
6.2.3 By Region - Global Submucosal Injectable Composition Revenue Market Share, 2017-2028
6.3 By Region - Global Submucosal Injectable Composition Sales & Forecasts
6.3.1 By Region - Global Submucosal Injectable Composition Sales, 2017-2022
6.3.2 By Region - Global Submucosal Injectable Composition Sales, 2023-2028
6.3.3 By Region - Global Submucosal Injectable Composition Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Submucosal Injectable Composition Revenue, 2017-2028
6.4.2 By Country - North America Submucosal Injectable Composition Sales, 2017-2028
6.4.3 US Submucosal Injectable Composition Market Size, 2017-2028
6.4.4 Canada Submucosal Injectable Composition Market Size, 2017-2028
6.4.5 Mexico Submucosal Injectable Composition Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Submucosal Injectable Composition Revenue, 2017-2028
6.5.2 By Country - Europe Submucosal Injectable Composition Sales, 2017-2028
6.5.3 Germany Submucosal Injectable Composition Market Size, 2017-2028
6.5.4 France Submucosal Injectable Composition Market Size, 2017-2028
6.5.5 U.K. Submucosal Injectable Composition Market Size, 2017-2028
6.5.6 Italy Submucosal Injectable Composition Market Size, 2017-2028
6.5.7 Russia Submucosal Injectable Composition Market Size, 2017-2028
6.5.8 Nordic Countries Submucosal Injectable Composition Market Size, 2017-2028
6.5.9 Benelux Submucosal Injectable Composition Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Submucosal Injectable Composition Revenue, 2017-2028
6.6.2 By Region - Asia Submucosal Injectable Composition Sales, 2017-2028
6.6.3 China Submucosal Injectable Composition Market Size, 2017-2028
6.6.4 Japan Submucosal Injectable Composition Market Size, 2017-2028
6.6.5 South Korea Submucosal Injectable Composition Market Size, 2017-2028
6.6.6 Southeast Asia Submucosal Injectable Composition Market Size, 2017-2028
6.6.7 India Submucosal Injectable Composition Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Submucosal Injectable Composition Revenue, 2017-2028
6.7.2 By Country - South America Submucosal Injectable Composition Sales, 2017-2028
6.7.3 Brazil Submucosal Injectable Composition Market Size, 2017-2028
6.7.4 Argentina Submucosal Injectable Composition Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Submucosal Injectable Composition Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Submucosal Injectable Composition Sales, 2017-2028
6.8.3 Turkey Submucosal Injectable Composition Market Size, 2017-2028
6.8.4 Israel Submucosal Injectable Composition Market Size, 2017-2028
6.8.5 Saudi Arabia Submucosal Injectable Composition Market Size, 2017-2028
6.8.6 UAE Submucosal Injectable Composition Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Boston Scientific
7.1.1 Boston Scientific Corporate Summary
7.1.2 Boston Scientific Business Overview
7.1.3 Boston Scientific Submucosal Injectable Composition Major Product Offerings
7.1.4 Boston Scientific Submucosal Injectable Composition Sales and Revenue in Global (2017-2022)
7.1.5 Boston Scientific Key News
7.2 The Standard
7.2.1 The Standard Corporate Summary
7.2.2 The Standard Business Overview
7.2.3 The Standard Submucosal Injectable Composition Major Product Offerings
7.2.4 The Standard Submucosal Injectable Composition Sales and Revenue in Global (2017-2022)
7.2.5 The Standard Key News
7.3 EndoClot Plus
7.3.1 EndoClot Plus Corporate Summary
7.3.2 EndoClot Plus Business Overview
7.3.3 EndoClot Plus Submucosal Injectable Composition Major Product Offerings
7.3.4 EndoClot Plus Submucosal Injectable Composition Sales and Revenue in Global (2017-2022)
7.3.5 EndoClot Plus Key News
7.4 GI Supply
7.4.1 GI Supply Corporate Summary
7.4.2 GI Supply Business Overview
7.4.3 GI Supply Submucosal Injectable Composition Major Product Offerings
7.4.4 GI Supply Submucosal Injectable Composition Sales and Revenue in Global (2017-2022)
7.4.5 GI Supply Key News
7.5 Cosmo Pharmaceuticals
7.5.1 Cosmo Pharmaceuticals Corporate Summary
7.5.2 Cosmo Pharmaceuticals Business Overview
7.5.3 Cosmo Pharmaceuticals Submucosal Injectable Composition Major Product Offerings
7.5.4 Cosmo Pharmaceuticals Submucosal Injectable Composition Sales and Revenue in Global (2017-2022)
7.5.5 Cosmo Pharmaceuticals Key News
7.6 Ovesco
7.6.1 Ovesco Corporate Summary
7.6.2 Ovesco Business Overview
7.6.3 Ovesco Submucosal Injectable Composition Major Product Offerings
7.6.4 Ovesco Submucosal Injectable Composition Sales and Revenue in Global (2017-2022)
7.6.5 Ovesco Key News
7.7 Seikagaku
7.7.1 Seikagaku Corporate Summary
7.7.2 Seikagaku Business Overview
7.7.3 Seikagaku Submucosal Injectable Composition Major Product Offerings
7.7.4 Seikagaku Submucosal Injectable Composition Sales and Revenue in Global (2017-2022)
7.7.5 Seikagaku Key News
8 GLOBAL SUBMUCOSAL INJECTABLE COMPOSITION PRODUCTION CAPACITY, ANALYSIS
8.1 Global Submucosal Injectable Composition Production Capacity, 2017-2028
8.2 Submucosal Injectable Composition Production Capacity of Key Manufacturers in Global Market
8.3 Global Submucosal Injectable Composition Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 SUBMUCOSAL INJECTABLE COMPOSITION SUPPLY CHAIN ANALYSIS
10.1 Submucosal Injectable Composition Industry Value Chain
10.2 Submucosal Injectable Composition Upstream Market
10.3 Submucosal Injectable Composition Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Submucosal Injectable Composition Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Submucosal Injectable Composition in Global Market
Table 2. Top Submucosal Injectable Composition Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Submucosal Injectable Composition Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Submucosal Injectable Composition Revenue Share by Companies, 2017-2022
Table 5. Global Submucosal Injectable Composition Sales by Companies, (K Units), 2017-2022
Table 6. Global Submucosal Injectable Composition Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Submucosal Injectable Composition Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Submucosal Injectable Composition Product Type
Table 9. List of Global Tier 1 Submucosal Injectable Composition Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Submucosal Injectable Composition Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Submucosal Injectable Composition Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Submucosal Injectable Composition Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Submucosal Injectable Composition Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Submucosal Injectable Composition Sales (K Units), 2017-2022
Table 15. By Type - Global Submucosal Injectable Composition Sales (K Units), 2023-2028
Table 16. By Application – Global Submucosal Injectable Composition Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Submucosal Injectable Composition Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Submucosal Injectable Composition Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Submucosal Injectable Composition Sales (K Units), 2017-2022
Table 20. By Application - Global Submucosal Injectable Composition Sales (K Units), 2023-2028
Table 21. By Region – Global Submucosal Injectable Composition Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Submucosal Injectable Composition Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Submucosal Injectable Composition Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Submucosal Injectable Composition Sales (K Units), 2017-2022
Table 25. By Region - Global Submucosal Injectable Composition Sales (K Units), 2023-2028
Table 26. By Country - North America Submucosal Injectable Composition Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Submucosal Injectable Composition Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Submucosal Injectable Composition Sales, (K Units), 2017-2022
Table 29. By Country - North America Submucosal Injectable Composition Sales, (K Units), 2023-2028
Table 30. By Country - Europe Submucosal Injectable Composition Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Submucosal Injectable Composition Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Submucosal Injectable Composition Sales, (K Units), 2017-2022
Table 33. By Country - Europe Submucosal Injectable Composition Sales, (K Units), 2023-2028
Table 34. By Region - Asia Submucosal Injectable Composition Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Submucosal Injectable Composition Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Submucosal Injectable Composition Sales, (K Units), 2017-2022
Table 37. By Region - Asia Submucosal Injectable Composition Sales, (K Units), 2023-2028
Table 38. By Country - South America Submucosal Injectable Composition Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Submucosal Injectable Composition Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Submucosal Injectable Composition Sales, (K Units), 2017-2022
Table 41. By Country - South America Submucosal Injectable Composition Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Submucosal Injectable Composition Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Submucosal Injectable Composition Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Submucosal Injectable Composition Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Submucosal Injectable Composition Sales, (K Units), 2023-2028
Table 46. Boston Scientific Corporate Summary
Table 47. Boston Scientific Submucosal Injectable Composition Product Offerings
Table 48. Boston Scientific Submucosal Injectable Composition Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. The Standard Corporate Summary
Table 50. The Standard Submucosal Injectable Composition Product Offerings
Table 51. The Standard Submucosal Injectable Composition Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. EndoClot Plus Corporate Summary
Table 53. EndoClot Plus Submucosal Injectable Composition Product Offerings
Table 54. EndoClot Plus Submucosal Injectable Composition Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. GI Supply Corporate Summary
Table 56. GI Supply Submucosal Injectable Composition Product Offerings
Table 57. GI Supply Submucosal Injectable Composition Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Cosmo Pharmaceuticals Corporate Summary
Table 59. Cosmo Pharmaceuticals Submucosal Injectable Composition Product Offerings
Table 60. Cosmo Pharmaceuticals Submucosal Injectable Composition Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Ovesco Corporate Summary
Table 62. Ovesco Submucosal Injectable Composition Product Offerings
Table 63. Ovesco Submucosal Injectable Composition Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Seikagaku Corporate Summary
Table 65. Seikagaku Submucosal Injectable Composition Product Offerings
Table 66. Seikagaku Submucosal Injectable Composition Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Submucosal Injectable Composition Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 68. Global Submucosal Injectable Composition Capacity Market Share of Key Manufacturers, 2020-2022
Table 69. Global Submucosal Injectable Composition Production by Region, 2017-2022 (K Units)
Table 70. Global Submucosal Injectable Composition Production by Region, 2023-2028 (K Units)
Table 71. Submucosal Injectable Composition Market Opportunities & Trends in Global Market
Table 72. Submucosal Injectable Composition Market Drivers in Global Market
Table 73. Submucosal Injectable Composition Market Restraints in Global Market
Table 74. Submucosal Injectable Composition Raw Materials
Table 75. Submucosal Injectable Composition Raw Materials Suppliers in Global Market
Table 76. Typical Submucosal Injectable Composition Downstream
Table 77. Submucosal Injectable Composition Downstream Clients in Global Market
Table 78. Submucosal Injectable Composition Distributors and Sales Agents in Global Market
Table 1. Key Players of Submucosal Injectable Composition in Global Market
Table 2. Top Submucosal Injectable Composition Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Submucosal Injectable Composition Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Submucosal Injectable Composition Revenue Share by Companies, 2017-2022
Table 5. Global Submucosal Injectable Composition Sales by Companies, (K Units), 2017-2022
Table 6. Global Submucosal Injectable Composition Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Submucosal Injectable Composition Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Submucosal Injectable Composition Product Type
Table 9. List of Global Tier 1 Submucosal Injectable Composition Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Submucosal Injectable Composition Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Submucosal Injectable Composition Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Submucosal Injectable Composition Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Submucosal Injectable Composition Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Submucosal Injectable Composition Sales (K Units), 2017-2022
Table 15. By Type - Global Submucosal Injectable Composition Sales (K Units), 2023-2028
Table 16. By Application – Global Submucosal Injectable Composition Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Submucosal Injectable Composition Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Submucosal Injectable Composition Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Submucosal Injectable Composition Sales (K Units), 2017-2022
Table 20. By Application - Global Submucosal Injectable Composition Sales (K Units), 2023-2028
Table 21. By Region – Global Submucosal Injectable Composition Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Submucosal Injectable Composition Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Submucosal Injectable Composition Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Submucosal Injectable Composition Sales (K Units), 2017-2022
Table 25. By Region - Global Submucosal Injectable Composition Sales (K Units), 2023-2028
Table 26. By Country - North America Submucosal Injectable Composition Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Submucosal Injectable Composition Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Submucosal Injectable Composition Sales, (K Units), 2017-2022
Table 29. By Country - North America Submucosal Injectable Composition Sales, (K Units), 2023-2028
Table 30. By Country - Europe Submucosal Injectable Composition Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Submucosal Injectable Composition Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Submucosal Injectable Composition Sales, (K Units), 2017-2022
Table 33. By Country - Europe Submucosal Injectable Composition Sales, (K Units), 2023-2028
Table 34. By Region - Asia Submucosal Injectable Composition Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Submucosal Injectable Composition Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Submucosal Injectable Composition Sales, (K Units), 2017-2022
Table 37. By Region - Asia Submucosal Injectable Composition Sales, (K Units), 2023-2028
Table 38. By Country - South America Submucosal Injectable Composition Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Submucosal Injectable Composition Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Submucosal Injectable Composition Sales, (K Units), 2017-2022
Table 41. By Country - South America Submucosal Injectable Composition Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Submucosal Injectable Composition Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Submucosal Injectable Composition Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Submucosal Injectable Composition Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Submucosal Injectable Composition Sales, (K Units), 2023-2028
Table 46. Boston Scientific Corporate Summary
Table 47. Boston Scientific Submucosal Injectable Composition Product Offerings
Table 48. Boston Scientific Submucosal Injectable Composition Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. The Standard Corporate Summary
Table 50. The Standard Submucosal Injectable Composition Product Offerings
Table 51. The Standard Submucosal Injectable Composition Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. EndoClot Plus Corporate Summary
Table 53. EndoClot Plus Submucosal Injectable Composition Product Offerings
Table 54. EndoClot Plus Submucosal Injectable Composition Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. GI Supply Corporate Summary
Table 56. GI Supply Submucosal Injectable Composition Product Offerings
Table 57. GI Supply Submucosal Injectable Composition Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Cosmo Pharmaceuticals Corporate Summary
Table 59. Cosmo Pharmaceuticals Submucosal Injectable Composition Product Offerings
Table 60. Cosmo Pharmaceuticals Submucosal Injectable Composition Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Ovesco Corporate Summary
Table 62. Ovesco Submucosal Injectable Composition Product Offerings
Table 63. Ovesco Submucosal Injectable Composition Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Seikagaku Corporate Summary
Table 65. Seikagaku Submucosal Injectable Composition Product Offerings
Table 66. Seikagaku Submucosal Injectable Composition Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Submucosal Injectable Composition Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 68. Global Submucosal Injectable Composition Capacity Market Share of Key Manufacturers, 2020-2022
Table 69. Global Submucosal Injectable Composition Production by Region, 2017-2022 (K Units)
Table 70. Global Submucosal Injectable Composition Production by Region, 2023-2028 (K Units)
Table 71. Submucosal Injectable Composition Market Opportunities & Trends in Global Market
Table 72. Submucosal Injectable Composition Market Drivers in Global Market
Table 73. Submucosal Injectable Composition Market Restraints in Global Market
Table 74. Submucosal Injectable Composition Raw Materials
Table 75. Submucosal Injectable Composition Raw Materials Suppliers in Global Market
Table 76. Typical Submucosal Injectable Composition Downstream
Table 77. Submucosal Injectable Composition Downstream Clients in Global Market
Table 78. Submucosal Injectable Composition Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Submucosal Injectable Composition Segment by Type
Figure 2. Submucosal Injectable Composition Segment by Application
Figure 3. Global Submucosal Injectable Composition Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Submucosal Injectable Composition Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Submucosal Injectable Composition Revenue, 2017-2028 (US$, Mn)
Figure 7. Submucosal Injectable Composition Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Submucosal Injectable Composition Revenue in 2021
Figure 9. By Type - Global Submucosal Injectable Composition Sales Market Share, 2017-2028
Figure 10. By Type - Global Submucosal Injectable Composition Revenue Market Share, 2017-2028
Figure 11. By Type - Global Submucosal Injectable Composition Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Submucosal Injectable Composition Sales Market Share, 2017-2028
Figure 13. By Application - Global Submucosal Injectable Composition Revenue Market Share, 2017-2028
Figure 14. By Application - Global Submucosal Injectable Composition Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Submucosal Injectable Composition Sales Market Share, 2017-2028
Figure 16. By Region - Global Submucosal Injectable Composition Revenue Market Share, 2017-2028
Figure 17. By Country - North America Submucosal Injectable Composition Revenue Market Share, 2017-2028
Figure 18. By Country - North America Submucosal Injectable Composition Sales Market Share, 2017-2028
Figure 19. US Submucosal Injectable Composition Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Submucosal Injectable Composition Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Submucosal Injectable Composition Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Submucosal Injectable Composition Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Submucosal Injectable Composition Sales Market Share, 2017-2028
Figure 24. Germany Submucosal Injectable Composition Revenue, (US$, Mn), 2017-2028
Figure 25. France Submucosal Injectable Composition Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Submucosal Injectable Composition Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Submucosal Injectable Composition Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Submucosal Injectable Composition Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Submucosal Injectable Composition Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Submucosal Injectable Composition Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Submucosal Injectable Composition Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Submucosal Injectable Composition Sales Market Share, 2017-2028
Figure 33. China Submucosal Injectable Composition Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Submucosal Injectable Composition Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Submucosal Injectable Composition Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Submucosal Injectable Composition Revenue, (US$, Mn), 2017-2028
Figure 37. India Submucosal Injectable Composition Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Submucosal Injectable Composition Revenue Market Share, 2017-2028
Figure 39. By Country - South America Submucosal Injectable Composition Sales Market Share, 2017-2028
Figure 40. Brazil Submucosal Injectable Composition Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Submucosal Injectable Composition Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Submucosal Injectable Composition Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Submucosal Injectable Composition Sales Market Share, 2017-2028
Figure 44. Turkey Submucosal Injectable Composition Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Submucosal Injectable Composition Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Submucosal Injectable Composition Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Submucosal Injectable Composition Revenue, (US$, Mn), 2017-2028
Figure 48. Global Submucosal Injectable Composition Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Submucosal Injectable Composition by Region, 2021 VS 2028
Figure 50. Submucosal Injectable Composition Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Submucosal Injectable Composition Segment by Type
Figure 2. Submucosal Injectable Composition Segment by Application
Figure 3. Global Submucosal Injectable Composition Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Submucosal Injectable Composition Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Submucosal Injectable Composition Revenue, 2017-2028 (US$, Mn)
Figure 7. Submucosal Injectable Composition Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Submucosal Injectable Composition Revenue in 2021
Figure 9. By Type - Global Submucosal Injectable Composition Sales Market Share, 2017-2028
Figure 10. By Type - Global Submucosal Injectable Composition Revenue Market Share, 2017-2028
Figure 11. By Type - Global Submucosal Injectable Composition Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Submucosal Injectable Composition Sales Market Share, 2017-2028
Figure 13. By Application - Global Submucosal Injectable Composition Revenue Market Share, 2017-2028
Figure 14. By Application - Global Submucosal Injectable Composition Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Submucosal Injectable Composition Sales Market Share, 2017-2028
Figure 16. By Region - Global Submucosal Injectable Composition Revenue Market Share, 2017-2028
Figure 17. By Country - North America Submucosal Injectable Composition Revenue Market Share, 2017-2028
Figure 18. By Country - North America Submucosal Injectable Composition Sales Market Share, 2017-2028
Figure 19. US Submucosal Injectable Composition Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Submucosal Injectable Composition Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Submucosal Injectable Composition Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Submucosal Injectable Composition Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Submucosal Injectable Composition Sales Market Share, 2017-2028
Figure 24. Germany Submucosal Injectable Composition Revenue, (US$, Mn), 2017-2028
Figure 25. France Submucosal Injectable Composition Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Submucosal Injectable Composition Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Submucosal Injectable Composition Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Submucosal Injectable Composition Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Submucosal Injectable Composition Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Submucosal Injectable Composition Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Submucosal Injectable Composition Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Submucosal Injectable Composition Sales Market Share, 2017-2028
Figure 33. China Submucosal Injectable Composition Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Submucosal Injectable Composition Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Submucosal Injectable Composition Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Submucosal Injectable Composition Revenue, (US$, Mn), 2017-2028
Figure 37. India Submucosal Injectable Composition Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Submucosal Injectable Composition Revenue Market Share, 2017-2028
Figure 39. By Country - South America Submucosal Injectable Composition Sales Market Share, 2017-2028
Figure 40. Brazil Submucosal Injectable Composition Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Submucosal Injectable Composition Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Submucosal Injectable Composition Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Submucosal Injectable Composition Sales Market Share, 2017-2028
Figure 44. Turkey Submucosal Injectable Composition Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Submucosal Injectable Composition Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Submucosal Injectable Composition Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Submucosal Injectable Composition Revenue, (US$, Mn), 2017-2028
Figure 48. Global Submucosal Injectable Composition Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Submucosal Injectable Composition by Region, 2021 VS 2028
Figure 50. Submucosal Injectable Composition Industry Value Chain
Figure 51. Marketing Channels
